Literature DB >> 24271834

Influence of malnutrition on the disposition of metronidazole in rats.

D Jung1, A Shah.   

Abstract

The influence of dietary protein deficiency on the disposition of metronidazole and its two major metabolites was examined in male Sprague-Dawley rats fed for 4 weeks on a 23% (control-) or a 5% (low-) protein diet ad libitum. Following an intravenous bolus dose of 10 mg/kg metronidazole hydrochloride, blood samples were obtained serially for a period of 24 hr after drug administration. Serum concentration-time data were analyzed by nonlinear least-squares regression, as well as noncompartmental techniques. The average mean residence time (MRT) was significantly prolonged by 48%, while the systemic clearance (Cl) was decreased by 42% in the protein-deficient rats. Since there was no alteration in the apparent steady-state volume of distribution (V ss), the mean harmonic half-life was increased from 2.9 to 5.0 hr in the protein-deficient rats. Although the percentage of metronidazole recovered as total drug in the urine over 24 hr was not significantly different between the two groups of animals, rats on a low-protein diet excreted a significantly smaller percentage of the administered dose as unchanged metronidazole (mean ± SD, 24.6 ± 3.8 vs 36.5 ± 12%) and a larger percentage (16.7 ± 2.6 vs 8.3 ± 1.8%) as the hydroxylated metabolite. No significant difference in the partial metabolic clearance of the hydroxylated metabolite of metronidazole was seen between the two groups of animals; however, there was a significant decrease in the renal clearance of metronidazole (1.45 ± 0.68 vs 0.55 ± 0.06 ml/min/kg) in the rats fed a low-protein diet. We conclude that the decreased clearance of metronidazole in protein deficiency is a result primarily of the decreased glomerular filtration rate, decreased biliary excretion, and/or increased net tubular reabsorption of metronidazole.

Entities:  

Year:  1986        PMID: 24271834     DOI: 10.1023/A:1016433724142

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

Review 1.  Nutrition and drug-metabolizing enzymes.

Authors:  T C Campbell
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

2.  Drug use in the Third World.

Authors: 
Journal:  Lancet       Date:  1980-12-06       Impact factor: 79.321

Review 3.  Drug disposition in children with protein energy malnutrition.

Authors:  S Mehta
Journal:  J Pediatr Gastroenterol Nutr       Date:  1983       Impact factor: 2.839

4.  The effect of dietary protein on the clearance of allopurinol and oxypurinol.

Authors:  W G Berlinger; G D Park; R Spector
Journal:  N Engl J Med       Date:  1985-09-26       Impact factor: 91.245

5.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

6.  Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion.

Authors:  R E Galinsky; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

7.  Comparative pharmacokinetic studies of ornidazole and metronidazole in man.

Authors:  D E Schwartz; F Jeunet
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

8.  Trichomonal vaginitis: epidemiology and therapy.

Authors:  W F Peterson; F W Hansen; J E Stauch; C D Ryder
Journal:  Am J Obstet Gynecol       Date:  1967-02-15       Impact factor: 8.661

9.  Metronidazole in prevention of cholestasis associated with total parenteral nutrition.

Authors:  J P Capron; J L Gineston; M A Herve; A Braillon
Journal:  Lancet       Date:  1983-02-26       Impact factor: 79.321

10.  Pharmacokinetics of theophylline in protein-calorie malnutrition.

Authors:  D Jung
Journal:  Biopharm Drug Dispos       Date:  1985 Jul-Sep       Impact factor: 1.627

View more
  1 in total

1.  The effect of dietary energy and protein deficiency on drug metabolism.

Authors:  O Hamberg; L Ovesen; A Dorfeldt; S Loft; J Sonne
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.